Chairman of the Board
Anders is an experienced executive and leader with extensive business knowledge from senior roles in the biopharmaceutical industry spanning global functions and countries to deliver products, projects, productivity and change management.
He is currently a Non-Executive Board Member of the Swedish Research Council, and several biotechnology companies including Alligator Bioscience AB (Sweden), LEO Pharma (DK), Mereo BioPharma Group Plc (UK). During his 20 year tenure at AstraZeneca, he was a member of global executive teams including Executive VP Global Medicines Development; Global Head Clinical Development; and, CEO at AstraZeneca AB Sweden. Anders is also a board certified MD (Anesthesiology and Intensive Care), PhD, DDS; Associate Professor at Karolinska Institute, Stockholm, Sweden; and, a fellow of the Royal Swedish Academy of Engineering Sciences.